Skip to main content
TipRanks
Go Ultimate75% OFF

Vir Biotechnology (VIR) Hedge Fund Trading Activity

1,580 Followers
Trend: ▲ Hedge Funds Increased Holdings by 2.2M Shares Last Quarter

Hedge Fund Holdings in VIR

16.00M$4.0018.00M$6.5020.00M$9.0022.00M$11.5024.00M$14.00Jan '25Jul '25Jan '26Jul '26$9.25Stock PriceShares Held by Hedge Funds

Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.

Hedge Fund Confidence Signal

Unlock Hedge Fund Confidence Signal

Hedge Fund Activity​

Activity
Star Ranking
Hedge fund activity
John Hussman hedge funds manager, Hussman Strategic Advisors Inc,Rank 374John HussmanHussman Strategic Advisors IncNew100.00%$1,173,9000.27%
Michael Rockefeller hedge funds manager, Woodline Partners LP,Rank 459Michael RockefellerWoodline Partners LPNew100.00%$1,038,085<0.01%
Kenneth Tropin hedge funds manager, Graham Capital Management, L.P.,Rank 66Kenneth TropinGraham Capital Management, L.P.New100.00%$228,810<0.01%
BlackRock, Inc. hedge funds manager,  ,Rank 334BlackRock, Inc. Added8.56%$250,978,937<0.01%
Andrew Law hedge funds manager, Caxton Associates LP,Rank 410Andrew LawCaxton Associates LPNot Changed0.00%$797,6710.03%
Antony J. Abbiati hedge funds manager, SCS Capital Management LLC,Rank 143Antony J. AbbiatiSCS Capital Management LLCNot Changed0.00%$270,556<0.01%
Michael Price hedge funds manager, Empyrean Capital Partners, LP,Rank 446Michael PriceEmpyrean Capital Partners, LPSold Out-100.00%$00.00%

FAQ

Which hedge funds hold Vir Biotechnology?
The hedge funds that hold the most shares in Vir Biotechnology are John Hussman, Michael Price and Antony J. Abbiati.
Are hedge funds buying or selling VIR?
In the last quarter hedge funds have Increased their holdings in Vir Biotechnology by 2.2M shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Vir Biotechnology stock?
Warren Buffet currently does not own shares in Vir Biotechnology.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here